COTTONWOOD HEIGHTS, Utah, Feb. 1, 2016 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: DYNT) today reported that the company has received approval to market its flagship SolarisPlus Series product line from the Health Sciences Authority of Singapore and the Ministry of Health of Peru. Dynatronics expects to begin marketing the SolarisPlus Series in both markets through distributors to physical therapy and sports medicine clinicians during the first quarter of calendar 2016.
"Building international revenue is a cornerstone of our growth strategy and these two approvals illustrate continued successful execution by our team," said Kelvyn H. Cullimore, Jr., Chairman & CEO of Dynatronics. "Over the past several years, we have worked to expand our distribution network with efforts in China, Japan, Mexico, Europe, Malaysia and several other countries. Most recently, we gained approval to market the SolarisPlus series in Europe as well as many countries that recognize the CE Mark and require this distinguished mark of quality. During 2016, one of our goals is to increase the percentage of our total revenue generated from international customers."
The Solaris Plus product line consists of four separate units that are capable of providing seven waveforms of electrotherapy along with Dynatronics' proprietary three-frequency ultrasound therapy, phototherapy and thermal therapy, allowing practitioners to select the optimal treatment for their patients. Since commercial launch in 2012, thousands of SolarisPlus units have been placed into service by physical therapists, athletic trainers and medical practitioners.
Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry and other related medical markets. More information regarding Dynatronics is available at www.dynatronics.com.
This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost-effective rates and the risk factors listed from time to time in the company's SEC reports.
SOURCE Dynatronics Corporation